» Articles » PMID: 29916103

Circulating MicroRNAs: a Potential Biomarker for Cardiac Damage, Inflammatory Response, and Left Ventricular Function Recovery in Pediatric Viral Myocarditis

Overview
Publisher Springer
Date 2018 Jun 20
PMID 29916103
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Viral myocarditis (VM) can be a life-threatening event resulting in cardiac failure, chronic cardiomyopathy, and death. VM typically includes three phases, i.e., acute, subacute, and resolution/chronic. We prospectively investigated cardiac- and inflammatory-associated plasma-circulating miRNA levels in eight pediatric patients with VM during the three stages of the disease. The level of cardiac-associated miR-208a was significantly elevated during the acute phase compared with the subacute and resolution/chronic phases. The level of cardiac- and inflammatory-associated miR-21 was significantly elevated during the acute phase compared to the resolution/chronic phase. Moreover, cardiac-associated miR-208b levels during the subacute phase correlated with systolic left ventricular function recovery as measured during the resolution/chronic phase. The findings of our study demonstrate an association between cardiac damage and the inflammatory response and the expression of miR-208a and miR-21 during the pathological progression of myocarditis. We also found that miR-208b levels exhibit a prognostic significance for left ventricular functional recovery.

Citing Articles

Role of non-coding RNAs in the pathogenesis of viral myocarditis.

Kang Z, Zhang L, Yang Z Virulence. 2025; 16(1):2466480.

PMID: 39950847 PMC: 11849450. DOI: 10.1080/21505594.2025.2466480.


The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis.

Mlynarska E, Badura K, Kurcinski S, Sinkowska J, Jakubowska P, Rysz J Int J Mol Sci. 2024; 25(20).

PMID: 39456716 PMC: 11507602. DOI: 10.3390/ijms252010933.


Hsa-circ-ACSL1 Enhances Apoptosis and Autophagy in Myocarditis Cardiomyocytes Through the miR-7-5p/XBP1 Axis.

Liang F, Tong Y, Zhang X, Ma X Anatol J Cardiol. 2024; .

PMID: 39378323 PMC: 11537450. DOI: 10.14744/AnatolJCardiol.2024.4472.


Artificial intelligence and myocarditis-a systematic review of current applications.

Lajczak P, Jozwik K Heart Fail Rev. 2024; 29(6):1217-1234.

PMID: 39138803 PMC: 11455665. DOI: 10.1007/s10741-024-10431-9.


Role of miRNA in Cardiovascular Diseases in Children-Systematic Review.

Paslawska M, Grodzka A, Peczynska J, Sawicka B, Bossowski A Int J Mol Sci. 2024; 25(2).

PMID: 38256030 PMC: 10816020. DOI: 10.3390/ijms25020956.


References
1.
Tian J, An X, Niu L . Role of microRNAs in cardiac development and disease. Exp Ther Med. 2017; 13(1):3-8. PMC: 5244779. DOI: 10.3892/etm.2016.3932. View

2.
Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M . Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Card Fail. 2010; 16(5):404-10. DOI: 10.1016/j.cardfail.2010.01.002. View

3.
Cheng Y, Zhang C . MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res. 2010; 3(3):251-5. PMC: 3611957. DOI: 10.1007/s12265-010-9169-7. View

4.
Kuehbacher A, Urbich C, Zeiher A, Dimmeler S . Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res. 2007; 101(1):59-68. DOI: 10.1161/CIRCRESAHA.107.153916. View

5.
Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View